KOPRAN
|
The Current P/B Ratio of KOPRAN is 2.48.
| Share Price | ₹271.3 | Sep 24,2026 |
| Market Cap | ₹1,310.1 Cr | |
| Book Value | ₹528.9 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.48x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹1,310.1 Cr] as on Sep 24,2026
(/) Book Value [ ₹528.9 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.48x ]
Thus, for KOPRAN , the investors are currently willing to pay '2.48 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.91x.
- KOPRAN 's operated at median p/b ratio of 1.64x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2026 of 0.99x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| KOPRAN | 528.90 | 2.48 | 1,310.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.32 | 444,597.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 15.23 | 255,195.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.38 | 187,712.0 |
| CIPLA LTD | 34,369.40 | 3.30 | 113,423.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.65 | 100,195.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.29 | 102,229.0 |
| LUPIN LTD | 22,384.10 | 4.29 | 95,939.4 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.34 | 117,705.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.61 | 98,965.0 |
| LAURUS LABS LTD | 5,275.08 | 20.75 | 109,481.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.48x |
| Max industry PB | 22.38x |
| Median industry PB | 4.34x |
| Average industry PB | 8.15x |
You may also like the below Video Courses